Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 15/20 | 0.67 |
| ▸ | CA2 | P00918 | 15/20 | 0.67 |
| ▸ | CA9 | Q16790 | 13/20 | 0.67 |
| ▸ | CA12 | O43570 | 4/20 | 0.67 |
| ▸ | CA7 | P43166 | 4/20 | 0.67 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.67 |
| ▸ | CA3 | P07451 | 3/20 | 0.67 |
| ▸ | CA4 | P22748 | 3/20 | 0.67 |
| ▸ | CA6 | P23280 | 3/20 | 0.67 |
| ▸ | CA5A | P35218 | 3/20 | 0.67 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.67 |
| ▸ | RECQL | P46063 | 2/20 | 0.64 |
| ▸ | TSHR | P16473 | 2/20 | 0.64 |
| ▸ | GLA | P06280 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.64 |
| ▸ | BLM | P54132 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL364864 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL9097777 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL771782 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL5718521 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL1459889 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL10725960 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL5710133 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL185576 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL17336074 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 | |
| SCHEMBL44522 | 1.00 | CA1 (0.67) | CA1CA2CA9CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116673199-B | Coating method of three-proofing paint of circuit board and circuit board | 苏州银光电子有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-117898289-A | Pesticide synergist and pesticide composition thereof | 江苏鼎越科技有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-108666578-B | Lithium ion battery cathode water system binder composition and preparation process thereof | 上海洛法化工有限公司 | 2021-07-30 | — | — | CN | claimed |
| CN-111668489-A | Mixed type lithium ion battery silicon cathode aqueous binder and preparation process thereof | 上海洛法化工有限公司 | 2020-09-15 | — | — | CN | claimed |
| CN-108666578-A | A kind of negative electrode of lithium ion battery water system cementing compositions agent and its preparation process | 上海洛法化工有限公司 | 2018-10-16 | — | — | CN | claimed |
| WO-2015191686-A1 | METHODS OF ADMINISTERING METHYLNALTREXONE | SALIX PHARMACEUTICALS, INC. (US) | 2015-12-17 | — | — | WO | claimed |
| CN-116673199-B | Coating method of three-proofing paint of circuit board and circuit board | 苏州银光电子有限公司 | 2025-05-06 | — | — | CN | disclosed |
| US-12115467-B2 | Amine separation method using liquid chromatography | DAICEL CORPORATION (JP) | 2024-10-15 | — | — | US | disclosed |
| US-20240192100-A1 | METHOD FOR TREATING BIOLOGICAL SAMPLE | FUJIREBIO INC. (JP) | 2024-06-13 | — | — | US | disclosed |
| CN-117898289-A | Pesticide synergist and pesticide composition thereof | 江苏鼎越科技有限公司 | 2024-04-19 | — | — | CN | disclosed |
| EP-4317451-A1 | METHOD FOR TREATING BIOLOGICAL SAMPLE | Fujirebio Inc. (JP) | 2024-02-07 | — | — | EP | disclosed |
| CN-117136304-A | Method for processing biological sample | 富士瑞必欧株式会社 | 2023-11-28 | — | — | CN | disclosed |
| EP-3984615-B1 | AMINE SEPARATION METHOD USING LIQUID CHROMATOGRAPHY | DAICEL CORP (JP) | 2023-09-27 | — | — | EP | disclosed |
| EP-0129582-A4 | ORALLY ADMINISTERED BIOLOGICALLY ACTIVE PEPTIDES AND PROTEINS. | RESEARCH CORP (US) | 1987-09-02 | — | — | EP | disclosed |
| US-4654327-A | PEPTIDES, PROTEINS AND ANTINEOPLASTIC DRUGS FOR ENTERNAL ADMINISTRATION | RESEARCH CORP. (US) | 1987-03-31 | — | — | US | disclosed |
| EP-0198388-A2 | Enterally effective biologically active peptide or protein composition, method for the production thereof, and a pharmaceutical composition containing same | Research Corporation (US) | 1986-10-22 | — | — | EP | disclosed |
| US-4604376-A | PROTEIN OR PEPTIDE AND SULFATE CORE WITH AMMONIUM ION | RESEARCH CORPORATION (US) | 1986-08-05 | — | — | US | disclosed |
| US-4582820-A | Orally administered biologically active peptides and proteins | RESEARCH CORPORATION (US) | 1986-04-15 | — | — | US | disclosed |
| EP-0129582-A1 | ORALLY ADMINISTERED BIOLOGICALLY ACTIVE PEPTIDES AND PROTEINS | University of Washington (US) | 1985-01-02 | — | — | EP | disclosed |
| WO-1984002467-A1 | ORALLY ADMINISTERED BIOLOGICALLY ACTIVE PEPTIDES AND PROTEINS | RESEARCH CORP (US) | 1984-07-05 | — | — | WO | disclosed |